FDA Public Service Announcement
On July 8, 2020, the FDA posted the following Public Service Announcement:
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity.
The direct link to the FDA Announcement is provided below:
If you or a loved one has been injured due to a dangerous and defective product, contact La Sorsa & Beneventano for a free and confidential consultation. Call – (914) 682-3300 OR email
ATTORNEY ADVERTISING: PRIOR RESULTS DO NOT GUARANTY A SIMILAR OUTCOME IN YOUR CASE